These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 39206194)

  • 1. New perspectives on chemokines in hepatocellular carcinoma therapy: a critical pathway for natural products regulation of the tumor microenvironment.
    Ruishi X; Linyi X; Yunfan B; Wenbo Y; Xiaoying Z; Xiaoxue F; Difu Z; Xintian L; Ming Z; Haoming L
    Front Immunol; 2024; 15():1456405. PubMed ID: 39206194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of chemokines in hepatocellular carcinoma (Review).
    Xue D; Zheng Y; Wen J; Han J; Tuo H; Liu Y; Peng Y
    Oncol Rep; 2021 Mar; 45(3):809-823. PubMed ID: 33650640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemokines and hepatocellular carcinoma.
    Huang F; Geng XP
    World J Gastroenterol; 2010 Apr; 16(15):1832-6. PubMed ID: 20397259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemokines in hepatocellular carcinoma: a meta-analysis.
    Pan X; Kaminga AC; Wen SW; Liu A
    Carcinogenesis; 2020 Dec; 41(12):1682-1694. PubMed ID: 33300549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PHLDA2 reshapes the immune microenvironment and induces drug resistance in hepatocellular carcinoma.
    Feng K; Peng H; Lv Q; Zhang Y
    Oncol Res; 2024; 32(6):1063-1078. PubMed ID: 38827322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory microenvironment and expression of chemokines in hepatocellular carcinoma.
    Han KQ; He XQ; Ma MY; Guo XD; Zhang XM; Chen J; Han H; Zhang WW; Zhu QG; Nian H; Ma LJ
    World J Gastroenterol; 2015 Apr; 21(16):4864-74. PubMed ID: 25944999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-Associated Neutrophils Recruit Macrophages and T-Regulatory Cells to Promote Progression of Hepatocellular Carcinoma and Resistance to Sorafenib.
    Zhou SL; Zhou ZJ; Hu ZQ; Huang XW; Wang Z; Chen EB; Fan J; Cao Y; Dai Z; Zhou J
    Gastroenterology; 2016 Jun; 150(7):1646-1658.e17. PubMed ID: 26924089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conditioning solid tumor microenvironment through inflammatory chemokines and S100 family proteins.
    Nasser MW; Elbaz M; Ahirwar DK; Ganju RK
    Cancer Lett; 2015 Aug; 365(1):11-22. PubMed ID: 25963887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma.
    Li X; Yao W; Yuan Y; Chen P; Li B; Li J; Chu R; Song H; Xie D; Jiang X; Wang H
    Gut; 2017 Jan; 66(1):157-167. PubMed ID: 26452628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD8
    Xu C; Lu X; Liu W; Chen A; Meng G; Zhang H; Li B; Zhang Y; Wu J; Wei J
    J Transl Med; 2018 May; 16(1):132. PubMed ID: 29784005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies Against Immune Checkpoint Molecules Restore Functions of Tumor-Infiltrating T Cells in Hepatocellular Carcinomas.
    Zhou G; Sprengers D; Boor PPC; Doukas M; Schutz H; Mancham S; Pedroza-Gonzalez A; Polak WG; de Jonge J; Gaspersz M; Dong H; Thielemans K; Pan Q; IJzermans JNM; Bruno MJ; Kwekkeboom J
    Gastroenterology; 2017 Oct; 153(4):1107-1119.e10. PubMed ID: 28648905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The roles of cancer stem cell-derived secretory factors in shaping the immunosuppressive tumor microenvironment in hepatocellular carcinoma.
    Muliawan GK; Lee TK
    Front Immunol; 2024; 15():1400112. PubMed ID: 38868769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer-associated fibroblasts promote hepatocellular carcinoma metastasis through chemokine-activated hedgehog and TGF-β pathways.
    Liu J; Chen S; Wang W; Ning BF; Chen F; Shen W; Ding J; Chen W; Xie WF; Zhang X
    Cancer Lett; 2016 Aug; 379(1):49-59. PubMed ID: 27216982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction of a risk score prognosis model based on hepatocellular carcinoma microenvironment.
    Zhang FP; Huang YP; Luo WX; Deng WY; Liu CQ; Xu LB; Liu C
    World J Gastroenterol; 2020 Jan; 26(2):134-153. PubMed ID: 31969776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signaling molecules in the microenvironment of hepatocellular carcinoma.
    Chen W; Tan M; Zhang H; Gao T; Ren J; Cheng S; Chen J
    Funct Integr Genomics; 2024 Aug; 24(5):146. PubMed ID: 39207523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study on the anti-tumor mechanism related to immune microenvironment of Bombyx Batryticatus on viral and non-viral infections of hepatocellular carcinoma.
    Yuan L; Bing Z; Han J; An X; Liu X; Li R; Wang C; Sun X; Yang L; Yang K
    Biomed Pharmacother; 2020 Apr; 124():109838. PubMed ID: 31981943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Burning down the house: Pyroptosis in the tumor microenvironment of hepatocellular carcinoma.
    Cheng C; Hsu SK; Chen YC; Liu W; Shu ED; Chien CM; Chiu CC; Chang WT
    Life Sci; 2024 Jun; 347():122627. PubMed ID: 38614301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beyond Cell Motility: The Expanding Roles of Chemokines and Their Receptors in Malignancy.
    Morein D; Erlichman N; Ben-Baruch A
    Front Immunol; 2020; 11():952. PubMed ID: 32582148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CXCL2/10/12/14 are prognostic biomarkers and correlated with immune infiltration in hepatocellular carcinoma.
    Lin T; Zhang E; Mai PP; Zhang YZ; Chen X; Peng LS
    Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 34085699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemokine clouding and liver cancer heterogeneity: Does it impact clinical outcomes?
    Ahmad M; Dhasmana A; Harne PS; Zamir A; Hafeez BB
    Semin Cancer Biol; 2022 Nov; 86(Pt 3):1175-1185. PubMed ID: 35189322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.